Vision Tech: Several Gene Therapies for Blindness Reach Clinical Trials

//Vision Tech: Several Gene Therapies for Blindness Reach Clinical Trials

Vision Tech: Several Gene Therapies for Blindness Reach Clinical Trials

ProQR Therapeutics is a Netherlands-based company currently researching RNA therapies to inhibit or counteract the harmful effects of the defective genes associated with the above retinal diseases. How does that work? As you may recall from biology class, genes are the building blocks for the proteins that build and maintain our bodies.

By | 2019-11-05T22:20:31-04:00 November 5th, 2019|News|Comments Off on Vision Tech: Several Gene Therapies for Blindness Reach Clinical Trials

About the Author: